San Francisco, CA, United States of America

Peter Seubert

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Prothena Biosciences Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Seubert. Retrieved from https://idiyas.com/inventor/peter-seubert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Seubert

Introduction

Peter Seubert is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of immunotherapy, particularly through his work on tau-associated pathologies. His innovative approach has the potential to impact the treatment of neurodegenerative diseases.

Latest Patents

Peter Seubert holds a patent for his invention related to tau immunotherapy. This invention provides antibodies that inhibit or delay tau-associated pathologies and the associated symptomatic deterioration. His work in this area is crucial for advancing therapeutic options for patients suffering from related conditions.

Career Highlights

Seubert is currently employed at Prothena Biosciences Limited, where he continues to develop groundbreaking therapies. His expertise in immunotherapy has positioned him as a key figure in the research and development of treatments targeting tau-related diseases.

Collaborations

Peter collaborates with talented individuals such as Philip James Dolan, III and Yue Liu. These partnerships enhance the research efforts at Prothena and contribute to the advancement of innovative therapies.

Conclusion

Peter Seubert's work in tau immunotherapy exemplifies the impact of innovation in the medical field. His contributions are paving the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…